Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Proteolytic System”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00002448
What this trial is testing

Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Study completedNCT00038519
What this trial is testing

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Who this might be right for
HIV Infections
Abbott 16
Post-approval studies (Phase 4)Ended earlyNCT00313144
What this trial is testing

Aralast alpha1-proteinase Inhibitor Surveillance Study

Who this might be right for
Alpha1-antitrypsin Deficiency
Baxalta now part of Shire 127
Large-scale testing (Phase 3)Study completedNCT00050895
What this trial is testing

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 775
Testing effectiveness (Phase 2)Study completedNCT00002452
What this trial is testing

A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken Indinavir

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 30
Not applicableUnknownNCT05817097
What this trial is testing

Effect of Dipeptidyl-4 Inhibitors in Reducing Stroke Severity, From HIRA Database

Who this might be right for
Cerebral InfarctionInfarction, BrainDipeptidyl-Peptidase IV Inhibitors
Ajou University School of Medicine 22,119
Testing effectiveness (Phase 2)Study completedNCT02683525
What this trial is testing

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Sherif S. Farag 37
Early research (Phase 1)Study completedNCT00357188
What this trial is testing

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

Who this might be right for
HIV InfectionsProtease Inhibitor
Bristol-Myers Squibb 22
Not applicableStudy completedNCT00001762
What this trial is testing

Magnetic Resonance Imaging of the Face and Bones

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 532
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT00002366
What this trial is testing

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Abbott
Post-approval studies (Phase 4)Study completedNCT00447070
What this trial is testing

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionsDyslipidemia
Foundation for Cardiovascular Research, Zurich 50
Not applicableStudy completedNCT00881543
What this trial is testing

"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"

Who this might be right for
Diabetes Type 2
University of Sao Paulo General Hospital 45
Post-approval studies (Phase 4)Study completedNCT00385957
What this trial is testing

Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100

Who this might be right for
HIV Infections
Hospital Clinic of Barcelona 70
Testing effectiveness (Phase 2)Study completedNCT00721890
What this trial is testing

Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma

Who this might be right for
Ovarian Carcinoma
CHU de Quebec-Universite Laval 16
Not applicableStudy completedNCT00007319
What this trial is testing

Carotid Artery Thickness in HIV Infected and Uninfected Adults

Who this might be right for
HIV InfectionsHIV SeronegativityAtherosclerosis
National Institute of Allergy and Infectious Diseases (NIAID) 132
Not applicableStudy completedNCT00002165
What this trial is testing

Viracept Expanded Access Program

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)WithdrawnNCT00006339
What this trial is testing

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00001084
What this trial is testing

Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation